278 related articles for article (PubMed ID: 27530150)
1. The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection.
Russmueller G; Seemann R; Weiss K; Stadler V; Speiss M; Perisanidis C; Fuereder T; Willinger B; Sulzbacher I; Steininger C
Sci Rep; 2016 Aug; 6():31604. PubMed ID: 27530150
[TBL] [Abstract][Full Text] [Related]
2. Role of microbiological culture and polymerase chain reaction (PCR) of actinomyces in medication-related osteonecrosis of the jaw (MRONJ).
Panya S; Fliefel R; Probst F; Tröltzsch M; Ehrenfeld M; Schubert S; Otto S
J Craniomaxillofac Surg; 2017 Mar; 45(3):357-363. PubMed ID: 28162845
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.
Naik NH; Russo TA
Clin Infect Dis; 2009 Dec; 49(11):1729-32. PubMed ID: 19886792
[TBL] [Abstract][Full Text] [Related]
4. Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw.
Zirk M; Wenzel C; Buller J; Zöller JE; Zinser M; Peters F
Clin Oral Investig; 2019 May; 23(5):2143-2151. PubMed ID: 30276516
[TBL] [Abstract][Full Text] [Related]
5. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
Hansen T; Kunkel M; Weber A; James Kirkpatrick C
J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
[TBL] [Abstract][Full Text] [Related]
6. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review.
Khominsky A; Lim M
Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095
[TBL] [Abstract][Full Text] [Related]
7. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Dodson TB
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
Ruggiero SL
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
[TBL] [Abstract][Full Text] [Related]
9. Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.
Akashi M; Wanifuchi S; Iwata E; Takeda D; Kusumoto J; Furudoi S; Komori T
Oral Maxillofac Surg; 2018 Mar; 22(1):59-63. PubMed ID: 29224060
[TBL] [Abstract][Full Text] [Related]
10. Actinomyces and MRONJ: A retrospective study and a literature review.
Cerrato A; Zanette G; Boccuto M; Angelini A; Valente M; Bacci C
J Stomatol Oral Maxillofac Surg; 2021 Nov; 122(5):499-504. PubMed ID: 32827811
[TBL] [Abstract][Full Text] [Related]
11. Shotgun metagenome sequencing identification of a set of genes encoded by Actinomyces associated with medication-related osteonecrosis of the jaw.
Yahara H; Hiraki A; Maruoka Y; Hirabayashi A; Suzuki M; Yahara K
PLoS One; 2020; 15(11):e0241676. PubMed ID: 33253207
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate and Medication-Related Osteonecrosis of the Jaw: A Review.
Mücke T; Krestan CR; Mitchell DA; Kirschke JS; Wutzl A
Semin Musculoskelet Radiol; 2016 Jul; 20(3):305-314. PubMed ID: 27741546
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic Cell Transplantation in Patients with Medication-Related Osteonecrosis of the Jaws.
Mawardi H; Glotzbecker B; Richardson P; Woo SB
Biol Blood Marrow Transplant; 2016 Feb; 22(2):344-348. PubMed ID: 26303103
[TBL] [Abstract][Full Text] [Related]
14. Role of Actinomyces spp. and related organisms in the development of medication-related osteonecrosis of the jaw (MRONJ): Clinical evidence based on a case series.
Kövér Z; Bán Á; Gajdács M; Polgár B; Urbán E
Eur J Microbiol Immunol (Bp); 2023 Dec; 13(4):125-134. PubMed ID: 38038751
[TBL] [Abstract][Full Text] [Related]
15. Targeted histological evaluation shows high incidence of actinomyces infection in medication-related osteonecrosis of the jaws.
Brody A; Scheich B; Dobo-Nagy C
Sci Rep; 2022 Mar; 12(1):3406. PubMed ID: 35233034
[TBL] [Abstract][Full Text] [Related]
16. Oral Abundance of Actinomyces spp. in Breast Cancer Patients.
Bilgilier C; Fuereder T; Kastner MT; Vass Z; Brandl I; Sahbegovic H; Singer CF; Steininger C
Oncology; 2022; 100(4):221-227. PubMed ID: 35051923
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
Otto S; Ristow O; Pache C; Troeltzsch M; Fliefel R; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study.
Kajizono M; Sada H; Sugiura Y; Soga Y; Kitamura Y; Matsuoka J; Sendo T
Biol Pharm Bull; 2015; 38(12):1850-5. PubMed ID: 26632176
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
[TBL] [Abstract][Full Text] [Related]
20. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
